PT Tempo Scan Pacific operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Tempo Scan Pacific with three other
pharmaceutical manufacturers in Asia:
CSPC Pharmaceutical Group Ltd
of Hong Kong
sales of 4.15 billion Hong Kong Dollars [US$534.27 million]
of which 41%
was Innovative Drugs and Antibiotics),
Chongkundang Holdings Corp
of South Korea
(595.43 billion Korean Won [US$555.54 million]
of which 103%
was Medicine), and
Zeria Pharmaceutical Co., Ltd.
based in Japan
(53.17 billion Japanese Yen [US$520.00 million]
of which 58%
was Medical Drugs).
PT Tempo Scan Pacific reported sales of 6.63 trillion Indonesian Rupiahs (US$571.58 million)
December of 2012.
increase of 14.7%
versus 2011, when the company's sales were 5.78 trillion Indonesian Rupiahs.
Sales at PT Tempo Scan Pacific have increased during each of the previous five years
(and since 2007, sales have increased a total of 112%).
Sales of Distribution Services saw an increase
18.7% in 2012, from
2.69 trillion Indonesian Rupiahs to 3.19 trillion Indonesian Rupiahs.